Citation: Dm. Galer et Am. Monro, EVALUATION OF THE TOXICITY OF DRUG RESIDUES IN FOOD - THE CASE FOR RELAY TOXICITY STUDIES, Food additives and contaminants, 15(4), 1998, pp. 494-500
Citation: Am. Monro et Js. Macdonald, EVALUATION OF THE CARCINOGENIC POTENTIAL OF PHARMACEUTICALS - OPPORTUNITIES ARISING FROM THE INTERNATIONAL-CONFERENCE ON HARMONIZATION, Drug safety, 18(5), 1998, pp. 309-319
Citation: Dm. Galer et Am. Monro, THE SAFETY ASSESSMENT OF DRUG RESIDUES AT INJECTION SITES, Journal of veterinary pharmacology and therapeutics, 19(4), 1996, pp. 312-312
Citation: Am. Monro, AUC AT MURINE LD(10)=AUC AT MTD FOR HUMANS - APPLICATION OF PHARMACOKINETICALLY GUIDED DOSE-ESCALATION WITH RESPECT TO CELL-CYCLE PHASE SPECIFICITY, Human & experimental toxicology, 13(11), 1994, pp. 783-784
Citation: G. Paulus et al., HUMAN CARCINOGENIC RISK ASSESSMENT BASED ON HORMONAL EFFECTS IN A CARCINOGENICITY STUDY IN RATS WITH THE ANTIFUNGAL AGENT, FLUCONAZOLE, Teratogenesis, carcinogenesis, and mutagenesis, 14(6), 1994, pp. 251-257
Citation: Am. Monro, ARE ROUTINE TISSUE DISTRIBUTION STUDIES JUSTIFIABLE FOR APPROVAL OF HUMAN DRUGS, Drug metabolism and disposition, 22(3), 1994, pp. 341-342